Biosimilars Forum Launches Education Initiative To Raise Awareness, Access

The Biosimilars Forum launched an education initiative Monday (Feb. 1) designed to help health care professionals, the media and patient advocacy organizations navigate the developing U.S. market with the release of two educational guides that explain what biosimilars are and how they are approved by FDA. The group, made up of generic and brand drug makers with significant biosimilar portfolios, is inviting other organizations to join the campaign. The organization's move comes just ahead of a Thursday (Feb. 4) House...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.